No Data
No Data
EC Healthcare Swings to Loss in Fiscal Year 2024
EC Healthcare Announces Key Annual Meeting
EC HEALTHCARE: ANNUAL REPORT 2023/2024
HTSC: Different performance for beauty and medical beauty in Q2. Q3 may be more challenging for new product sales during off-season.
In Q3 24, it is the off-season for the industry, but also an important window period for many brand manufacturers to prepare for the November 11 shopping festival. It is recommended to pay close attention to new product developments.
BOC International: Continued prosperity of upstream medical beauty manufacturers opens up space for external expansion.
According to the research reports released by BOC International, the performance of leading medical and aesthetic companies is still maintaining good growth, and the average product price has not shown any price reduction pressure. The constantly enriched product matrix is expected to bring growth in the future.
Stock market fluctuations | ec healthcare (02138) fell more than 5%, with a year-on-year decline of 85.3% in net profit to 15.7 million Hong Kong dollars.
Ec healthcare (02138) fell more than 5% in intraday trading. As of press time, it fell 4.62% to HKD 1.24 with a turnover of HKD 782,700.
No Data